1 Jun 2026
A multi-Level Study of 20S proteasome inhibitors: an integrated approach combining chemistry and ModellingPublisher siteJournal of Molecular Graphics and Modelling, Ubiquitin and proteasome pathways
Active, last published 2026
In computational drug discovery methods
Abdelouahid
Sbai
Scholar“Research focused on Computational Drug Discovery Methods and adjacent fields.”
Claim Your Profile19
H-index
1.0k
Citations
Abdelouahid has not officially claimed their profile. If you are Abdelouahid, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
bdelouahid Sbai is a researcher working on Computational Drug Discovery Methods. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Abdelouahid's work has been cited 1,031 times across 4 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Computational Drug Discovery Methods×43Synthesis and biological activity×39Synthesis and Characterization of Heterocyclic Compounds×8Click Chemistry and Applications×6Nonlinear Optical Materials Research×5
04 · Where I am
Affiliations
Affiliation on published researchUniversité Moulay Ismail de Meknes, MoroccoDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
24 works20 Mar 20252cites
Virtual Screening and Dynamic Simulation of Baloxavir Derivatives for Multitarget Breast Cancer TreatmentPublisher siteAnti-Cancer Agents in Medicinal Chemistry, Computational Drug Discovery Methods
10 Mar 202510cites
Pyrazole-benzimidazole derivatives targeting MCF-7 breast cancer cells as potential anti-proliferative agents. 3D QSAR and In-silico investigations via molecular docking and molecular dynamics simulationsPublisher siteComputers in Biology and Medicine, Computational Drug Discovery Methods
6 Jan 20259cites
Design, 3D-QSAR, molecular docking, MD simulations, ADME/Tox properties and DFT study of benzimidazole derivatives as promising α-glucosidase inhibitorsPublisher siteJournal of Molecular Structure, Synthesis and biological activity
29 Dec 2024Open access
Computational Study of Potential MAO-B Inhibitors Based on 4-(3-Nitrophenyl) Thiazol-2-ylhydrazone.Publisher siteTurkish computational and theoretical chemistry/Turkish computational and theoretical chemistry :, Computational Drug Discovery Methods
1 Jun 20242cites
Computational Prediction of Spiropyrazoline Derivatives as Potential Acetylcholinesterase Inhibitors for Alzheimer’s Disease TreatmentPublisher siteRussian Journal of Bioorganic Chemistry, Computational Drug Discovery Methods
2 Feb 2024Open access18cites
Design of new α-glucosidase inhibitors through a combination of 3D-QSAR, ADMET screening, molecular docking, molecular dynamics simulations and quantum studiesPublisher siteArabian Journal of Chemistry, Computational Drug Discovery Methods
9 Jan 202415cites
Computational evaluation of 1,2,3-triazole-based VEGFR-2 inhibitors: anti-angiogenesis potential and pharmacokinetic assessmentPublisher siteJournal of Biomolecular Structure and Dynamics, Click Chemistry and Applications
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Abdelouahid?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you